Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Morpholine-based chalcones as dual-acting monoamine oxidase-B and acetylcholinesterase inhibitors: synthesis and biochemical investigations
Rani Sasidharan, Bo Hyun Eom, Jeong Hyun Heo, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 188-197
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Synthetic strategies and medicinal chemistry perspectives of dual acting carbonic anhydrase modulators with monoamine oxidase and cholinesterase inhibitors
Sandeep Bindra, Ehab M. Mostafa, Mohamed A. Abdelgawad, et al.
RSC Medicinal Chemistry (2025)
Closed Access | Times Cited: 1
Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease
Siew Lee Cheong, Jian Kai Tiew, Yi Hang Fong, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1560-1560
Open Access | Times Cited: 43
Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer’s disease
Da-Jiang Zou, Renzheng Liu, Yangjing Lv, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 18
Microwave-Assisted Synthesis of Morpholine-Based Chalcones as Reversible MAO-A Inhibitors in the Management of Mental Depression
Diksha Choudhary, Bhupinder Kumar, Balakumar Chandrasekaran, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 309-309
Open Access
Antioxidants in Anti-Alzheimer's Disease Drug Discovery
Jianan Guo, Yalan Zhu, Jia Zhi, et al.
Ageing Research Reviews (2025) Vol. 107, pp. 102707-102707
Closed Access
Piperazine-substituted chalcones: a new class of MAO-B, AChE, and BACE-1 inhibitors for the treatment of neurological disorders
Bijo Mathew, Jong‐Min Oh, Roua S. Baty, et al.
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 29, pp. 38855-38866
Open Access | Times Cited: 38
An ongoing journey of chalcone analogues as single and multi-target ligands in the field of Alzheimer's disease: A review with structural aspects
Pratibha Sharma, Manjinder Singh
Life Sciences (2023) Vol. 320, pp. 121568-121568
Closed Access | Times Cited: 14
Dual-Target Inhibitors Based on Acetylcholinesterase: Novel Agents for Alzheimer's Disease
Xingyi Zhao, Qiaoguan Hu, Xiaoqian Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116810-116810
Closed Access | Times Cited: 4
Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders
Vishal Payyalot Vishal, Jong‐Min Oh, Ahmed Khames, et al.
Pharmaceutics (2021) Vol. 13, Iss. 6, pp. 850-850
Open Access | Times Cited: 29
Discovery of chalcone derivatives as potential α-glucosidase and cholinesterase inhibitors: Effect of hyperglycemia in paving a path to dementia
Hanan Al-Ghulikah, Ehsan Ullah Mughal, Eslam B. Elkaeed, et al.
Journal of Molecular Structure (2022) Vol. 1275, pp. 134658-134658
Closed Access | Times Cited: 21
Chalcones as Potential Ligands for the Treatment of Parkinson’s Disease
Ewelina Królicka, Katarzyna Kieć‐Kononowicz, Dorota Łażewska
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 847-847
Open Access | Times Cited: 20
Identification of New N-methyl-piperazine Chalcones as Dual MAO-B/AChE Inhibitors
Ashraf K. El‐Damasy, Jong‐Eun Park, Hyun Ji Kim, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 1, pp. 83-83
Open Access | Times Cited: 11
Benzimidazole-derived carbohydrazones as dual monoamine oxidases and acetylcholinesterase inhibitors: design, synthesis, and evaluation
Sandeep Kumar, Shivani Jaiswal, Sukesh Kumar Gupta, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 9, pp. 4710-4729
Closed Access | Times Cited: 11
Development of morpholine ring-bearing halogenated α,β-unsaturated ketones as selective monoamine oxidase-B inhibitors
Jiseong Lee, Saranya Kattil Parmbil, Nagendar Kumar Pandit, et al.
Applied Biological Chemistry (2024) Vol. 67, Iss. 1
Open Access | Times Cited: 3
Structural Modifications on Chalcone Framework for Developing New Class of Cholinesterase Inhibitors
Ginson George, Vishal Payyalot Koyiparambath, Sukumaran Sunitha, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3121-3121
Open Access | Times Cited: 15
Synthesis, crystal structure investigation and computational studies binding of (7S,8R)-7-acetyl-8-(4-chlorophenyl)-3-(ethylthio)-1,6-dimethyl-7,8-dihydroisoquinoline-4-carbonitrile with monoamine oxidase B
Etify A. Bakhite, S. Karthikeyan, Atazaz Ahsin, et al.
Journal of Molecular Structure (2024) Vol. 1307, pp. 137974-137974
Closed Access | Times Cited: 2
EGFR and COX-2 Dual Inhibitor: The Design, Synthesis, and Biological Evaluation of Novel Chalcones
Arafa Musa, Ehab M. Mostafa, Syed Nasir Abbas Bukhari, et al.
Molecules (2022) Vol. 27, Iss. 4, pp. 1158-1158
Open Access | Times Cited: 13
Chalcones bearing nitrogen‐containing heterocyclics as multi‐targeted inhibitors: Design, synthesis, biological evaluation and molecular docking studies
Yusuf Sıcak, Hüseyin Kekeçmuhammed, Ayşegül Karaküçük‐İyidoğan, et al.
Journal of Molecular Recognition (2023) Vol. 36, Iss. 7
Closed Access | Times Cited: 7
Ameliorative effect of ethoxylated chalcone-based MAO-B inhibitor on behavioural predictors of haloperidol-induced Parkinsonism in mice: evidence of its antioxidative role against Parkinson’s diseases
Naseer Maliyakkal, Uzma Saleem, Fareeha Anwar, et al.
Environmental Science and Pollution Research (2021) Vol. 29, Iss. 5, pp. 7271-7282
Closed Access | Times Cited: 13
Synthesis, Crystal Structure, Spectroscopic Characterization, in Vitro and in Silico Studies of Water-Soluble (Z)-N'-Hydroxy-2-Morpholinonicotinimidamide
Selvaraj Geetha, Rajendran Sribalan, S. Lakshmi
Journal of Structural Chemistry (2024) Vol. 65, Iss. 4, pp. 740-759
Closed Access | Times Cited: 1
Discovery of 3,4-dichloro-N-(1H-indol-5-yl)benzamide: A highly potent, selective, and competitive hMAO-B inhibitor with high BBB permeability profile and neuroprotective action
Ahmed Elkamhawy, Hyeon Jeong Kim, Mohamed H. Elsherbeny, et al.
Bioorganic Chemistry (2021) Vol. 116, pp. 105352-105352
Closed Access | Times Cited: 12
A Comprehensive Review of the Docking Studies of Chalcone for the Development of Selective MAO-B Inhibitors
Athulya Krishna, Sunil Kumar, Sachithra Thazhathuveedu Sudevan, et al.
CNS & Neurological Disorders - Drug Targets (2023) Vol. 23, Iss. 6, pp. 697-714
Closed Access | Times Cited: 4
An efficient and sustainable synthesis of morpholino-1,4-dihydropyridine-2,3-dicarboxylates using recyclable SeO2/HAp catalyst
Challa Madhavi, Alice R. Robert, Kranthi Kumar Gangu, et al.
Inorganic Chemistry Communications (2022) Vol. 143, pp. 109750-109750
Closed Access | Times Cited: 7
Design and synthesis of novel chalcone derivatives and evaluation of their inhibitory activities against acetylcholinesterase
İlçim Ceyhun, Şevval Karaca, Derya Osmani̇ye, et al.
Archiv der Pharmazie (2021) Vol. 355, Iss. 3
Closed Access | Times Cited: 10
Synthesis, in vitro, and in silico studies of new derivatives of diphenylpiperazine scaffold: A key substructure for MAO inhibition
Lamiaa O. El-Halaby, Walaa M. El-Husseiny, Shahenda M. El‐Messery, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 107011-107011
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top